Is there any consensus or guidance on how to manage germ cell tumor patients in the COVID-19 era?  

Germ Cell Tumor Management in face of SARS-CoV-2:  Safe, Rational Modifications to Standard GCT Practice to Protect Public Health, GCT Outcomes, GCT Patients, and Health Systems. This bulletin has been produced by a concerned group of international experts in germ cell tumors, has not undergon...